No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
ETNB250117C7500
- 0.60
- 0.000.00%
15min DelayClose Jan 10 16:00 ET
0.00High0.00Low
0.60Open0.60Pre Close0 Volume46 Open Interest7.50Strike Price0.00Turnover273.37%IV24.42%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier6DDays to Expiry0.60Extrinsic Value100Contract SizeAmericanOptions Type0.4206Delta0.1637Gamma10.85Leverage Ratio-0.0738Theta0.0004Rho4.56Eff Leverage0.0034Vega
Intraday
- 5D
- Daily
News
Cantor Fitzgerald Reiterates Overweight on 89bio, Maintains $29 Price Target
89bio Analyst Ratings
Cantor Fitzgerald Maintains 89bio(ETNB.US) With Buy Rating, Cuts Target Price to $29
89bio Strengthens Leadership Retention With New RSUs
Express News | 89Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)